Printer Friendly

BIOPLASTY, INC. ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER

 ST. PAUL, Minn., Feb. 22 /PRNewswire/ -- Bioplasty, Inc. (NASDAQ-NMS: BIOP) announced today the resignation of Timothy P. Lawin as president and chief executive officer of Bioplasty, Inc. Lawin will be devoting his time to the management of the former wound care business of Bioplasty, Inc., which he recently acquired. Lawin will remain a member of the board of directors of Bioplasty, Inc.
 The board of directors have appointed Daniel G. Holman, who is also chairman of the board, to succeed Lawin as president and chief executive officer of Bioplasty, Inc. effective immediately.
 Bioplasty, Inc. has more than 21 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ National Market System under the symbol "BIOP."
 -0- 2/22/93
 /CONTACT: Daniel G. Holman, president and CEO, or Donald A. Major, vice president of finance, 612-378-1180, both of Bioplasty/
 (BIOP)


CO: Bioplasty, Inc. ST: Minnesota IN: MTC SU: PER

AL -- MN022 -- 9109 02/22/93 17:44 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 22, 1993
Words:168
Previous Article:NORSTAN ANNOUNCES RECORD THIRD QUARTER NET INCOME AND YEAR-TO-DATE RESULTS
Next Article:IMPRESSION DELIVERY CORPORATION ACQUIRES AIDS-TREATMENT TECHNOLOGY
Topics:


Related Articles
BIOPLASTY, INC. ANNOUNCES FISCAL 1992 OPERATING RESULTS
BIOPLASTY ANNOUNCES APPOINTMENT OF LINDA ALEXANDER TO THE POSITION OF DIRECTOR OF REGULATORY AFFAIRS
UROPLASTY ANNOUNCES APPOINTMENT OF PRESIDENT AND CHIEF EXECUTIVE OFFICER
BIOPLASTY ANNOUNCES RESIGNATION OF CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
UROPLASTY ANNOUNCES APPOINTMENT OF PRESIDENT
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY, INC. REACHES TENTATIVE AGREEMENT TO SETTLE SHAREHOLDERS' SUIT
BIOPLASTY, INC. FILES PLAN OF REORGANIZATION

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters